Product NDC: | 0363-0374 |
Proprietary Name: | migraine relief |
Non Proprietary Name: | Acetaminophen, Aspirin, Caffeine |
Active Ingredient(s): | 250; 250; 65 mg/1; mg/1; mg/1 & nbsp; Acetaminophen, Aspirin, Caffeine |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0363-0374 |
Labeler Name: | Walgreen Company |
Product Type: | HUMAN OTC DRUG |
FDA Application Number: | ANDA075794 |
Marketing Category: | ANDA |
Start Marketing Date: | 20020502 |
Package NDC: | 0363-0374-85 |
Package Description: | 250 TABLET, FILM COATED in 1 BOTTLE (0363-0374-85) |
NDC Code | 0363-0374-85 |
Proprietary Name | migraine relief |
Package Description | 250 TABLET, FILM COATED in 1 BOTTLE (0363-0374-85) |
Product NDC | 0363-0374 |
Product Type Name | HUMAN OTC DRUG |
Non Proprietary Name | Acetaminophen, Aspirin, Caffeine |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20020502 |
Marketing Category Name | ANDA |
Labeler Name | Walgreen Company |
Substance Name | ACETAMINOPHEN; ASPIRIN; CAFFEINE |
Strength Number | 250; 250; 65 |
Strength Unit | mg/1; mg/1; mg/1 |
Pharmaceutical Classes |